Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid
- PMID: 17368876
- DOI: 10.1016/j.ejpb.2007.02.006
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid
Abstract
Cationic solid lipid nanoparticles (SLNs) have recently been suggested for non-viral gene delivery as a promising alternative to the liposomes. The aim of this study was to investigate the possibility to obtain re-dispersible cationic SLNs after a freeze-drying process in the absence of lyo- and/or cryoprotectors. The physical-chemical characteristics of cationic SLNs and their ability to bind gene material were investigated before and after the freeze-drying. To perform this study three samples of cationic SLNs, based on stearic acid, Compritol or cetylpalmitate, were prepared and characterized by PCS (photon correlation spectroscopy) and AFM (atomic force microscopy). The results indicated that solely the re-dispersed sample of stearic acid (SLN-SA) became very similar in terms of size and morphology to the fresh prepared sample, although it displayed a sensible reduction of the zeta potential (from 39.2 to 23.3 mV). By both the DSC (differential scanning calorimetry) and the ESCA (electron spectroscopy for chemical analysis) determinations, the reduction of the zeta potential was ascribed to the loss of the cationic lipids from the particle surface due to the rearrangement of the stearic acid lattice after the freeze-drying. Finally, the gel electrophoresis analysis demonstrated that SLN-SA re-suspended in PBS are unable to complex the DNA, while the SLN-SA re-dispersed in water displayed the same ability to bind DNA as the fresh prepared sample. We can conclude that cationic SLNs, based on stearic acid, retain the ability to complex DNA even after the freeze-drying in the absence of lyo- or cryoprotectors; thus, the powder form of this sample represents an attractive candidate to be investigated as in vivo DNA vector formulation.
Similar articles
-
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.Int J Pharm. 2010 Apr 15;389(1-2):254-61. doi: 10.1016/j.ijpharm.2010.01.030. Epub 2010 Jan 25. Int J Pharm. 2010. PMID: 20100555
-
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12. Int J Pharm. 2007. PMID: 17428627
-
Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.J Microencapsul. 2011;28(1):74-81. doi: 10.3109/02652048.2010.529948. J Microencapsul. 2011. PMID: 21171818
-
Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art.Expert Opin Drug Deliv. 2010 Jan;7(1):7-18. doi: 10.1517/17425240903362410. Expert Opin Drug Deliv. 2010. PMID: 20017658 Review.
-
Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.J Control Release. 2015 Mar 10;201:1-13. doi: 10.1016/j.jconrel.2015.01.010. Epub 2015 Jan 9. J Control Release. 2015. PMID: 25578828 Review.
Cited by
-
Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.Int J Pharm. 2010 Nov 15;400(1-2):251-9. doi: 10.1016/j.ijpharm.2010.08.044. Epub 2010 Sep 15. Int J Pharm. 2010. PMID: 20816930 Free PMC article.
-
A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity.Int J Pharm. 2019 Oct 30;570:118609. doi: 10.1016/j.ijpharm.2019.118609. Epub 2019 Aug 12. Int J Pharm. 2019. PMID: 31415878 Free PMC article.
-
Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.Int J Nanomedicine. 2012;7:2513-22. doi: 10.2147/IJN.S31915. Epub 2012 May 21. Int J Nanomedicine. 2012. PMID: 22679364 Free PMC article.
-
Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.Pharm Res. 2012 Jan;29(1):97-109. doi: 10.1007/s11095-011-0514-6. Epub 2011 Jul 6. Pharm Res. 2012. PMID: 21732152
-
Freeze-drying of bupivacaine lipospheres: preparation, characterization, and evaluation of anti-microbial properties.Daru. 2024 Jun;32(1):207-214. doi: 10.1007/s40199-024-00506-1. Epub 2024 Feb 29. Daru. 2024. PMID: 38421501 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous